Identification of recruited myeloid cells important for the development of hepatic metastasis

<p>Hepatic metastases are a frequent cause of mortality in colon cancer patients. Many patients with hepatic metastasis have large tumour burden, signaling the need for therapies capable of down-staging metastatic disease. Research evidence indicates that immune cells promote the metastasis of...

Cijeli opis

Bibliografski detalji
Glavni autor: Gordon-Weeks, A
Daljnji autori: Muschel, R
Format: Disertacija
Izdano: 2015
_version_ 1826306573019906048
author Gordon-Weeks, A
author2 Muschel, R
author_facet Muschel, R
Gordon-Weeks, A
author_sort Gordon-Weeks, A
collection OXFORD
description <p>Hepatic metastases are a frequent cause of mortality in colon cancer patients. Many patients with hepatic metastasis have large tumour burden, signaling the need for therapies capable of down-staging metastatic disease. Research evidence indicates that immune cells promote the metastasis of various primary cancers. We wish to determine whether immune cells play a role in the promotion of hepatic colon cancer metastasis.</p> <p>Using the well-characterised method of intrasplenic tumour cell injection, we developed hepatic metastases in both immunocompetent and immunoincompetent mice using a range of murine and human cancer cell lines. We analysed the immune cell infiltrates associated with hepatic metastases using flow cytometry and identified chemokines responsible for their recruitment using targeted protein arrays. The effect of immune cell depletion or inhibition of immune cell recruitment was determined using various <em>in-vivo</em> imaging techniques.</p> <p>Hepatic metastases developed using the murine colon cancer cell line MC38 were associated with CD11b<sup>+</sup>/Gr1<sup>mid</sup>/CCR2<sup>+</sup> monocytes, the recruitment of which was delayed by inhibition of tumour-derived CCL2. In contrast, human HT29, HCT-116 and LoVo hepatic metastases in SCID mice were associated with infiltrates of CD45<sup>+</sup>/CXCR2<sup>+</sup> neutrophils recruited in response to tumour-derived Macrophage Inhibitory Factor (MIF). Depletion of Gr1<sup>mid</sup> cells in CD11b-DTR transgenic mice delayed MC38 metastasis development, whilst neutrophil depletion using anti-Ly6G antibodies significantly inhibited the growth of HT29, HCT-116 and LoVo hepatic metastases. The neutrophils recruited to HT29, HCT-116 and LoVo hepatic metastases promoted angiogenesis, potentially through the expression of fibtroblast growth factor-2. This work demonstrates a role for myeloid cells in the development of hepatic metastasis from colon cancer and in doing so identifies various potential therapeutic targets.</p>
first_indexed 2024-03-07T06:49:59Z
format Thesis
id oxford-uuid:fc35cc76-0a69-4b1f-b5b7-4be94df1cd36
institution University of Oxford
last_indexed 2024-03-07T06:49:59Z
publishDate 2015
record_format dspace
spelling oxford-uuid:fc35cc76-0a69-4b1f-b5b7-4be94df1cd362022-03-27T13:19:10ZIdentification of recruited myeloid cells important for the development of hepatic metastasisThesishttp://purl.org/coar/resource_type/c_db06uuid:fc35cc76-0a69-4b1f-b5b7-4be94df1cd36ORA Deposit2015Gordon-Weeks, AMuschel, R<p>Hepatic metastases are a frequent cause of mortality in colon cancer patients. Many patients with hepatic metastasis have large tumour burden, signaling the need for therapies capable of down-staging metastatic disease. Research evidence indicates that immune cells promote the metastasis of various primary cancers. We wish to determine whether immune cells play a role in the promotion of hepatic colon cancer metastasis.</p> <p>Using the well-characterised method of intrasplenic tumour cell injection, we developed hepatic metastases in both immunocompetent and immunoincompetent mice using a range of murine and human cancer cell lines. We analysed the immune cell infiltrates associated with hepatic metastases using flow cytometry and identified chemokines responsible for their recruitment using targeted protein arrays. The effect of immune cell depletion or inhibition of immune cell recruitment was determined using various <em>in-vivo</em> imaging techniques.</p> <p>Hepatic metastases developed using the murine colon cancer cell line MC38 were associated with CD11b<sup>+</sup>/Gr1<sup>mid</sup>/CCR2<sup>+</sup> monocytes, the recruitment of which was delayed by inhibition of tumour-derived CCL2. In contrast, human HT29, HCT-116 and LoVo hepatic metastases in SCID mice were associated with infiltrates of CD45<sup>+</sup>/CXCR2<sup>+</sup> neutrophils recruited in response to tumour-derived Macrophage Inhibitory Factor (MIF). Depletion of Gr1<sup>mid</sup> cells in CD11b-DTR transgenic mice delayed MC38 metastasis development, whilst neutrophil depletion using anti-Ly6G antibodies significantly inhibited the growth of HT29, HCT-116 and LoVo hepatic metastases. The neutrophils recruited to HT29, HCT-116 and LoVo hepatic metastases promoted angiogenesis, potentially through the expression of fibtroblast growth factor-2. This work demonstrates a role for myeloid cells in the development of hepatic metastasis from colon cancer and in doing so identifies various potential therapeutic targets.</p>
spellingShingle Gordon-Weeks, A
Identification of recruited myeloid cells important for the development of hepatic metastasis
title Identification of recruited myeloid cells important for the development of hepatic metastasis
title_full Identification of recruited myeloid cells important for the development of hepatic metastasis
title_fullStr Identification of recruited myeloid cells important for the development of hepatic metastasis
title_full_unstemmed Identification of recruited myeloid cells important for the development of hepatic metastasis
title_short Identification of recruited myeloid cells important for the development of hepatic metastasis
title_sort identification of recruited myeloid cells important for the development of hepatic metastasis
work_keys_str_mv AT gordonweeksa identificationofrecruitedmyeloidcellsimportantforthedevelopmentofhepaticmetastasis